A large simple placebo controlled trial, among adults with head injury and impaired consciousness, of the effects of corticosteroids on death and disability

ISRCTN ISRCTN74459797
DOI https://doi.org/10.1186/ISRCTN74459797
Secondary identifying numbers G9722166
Submission date
23/10/2000
Registration date
23/10/2000
Last edited
11/07/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Ian Roberts
Scientific

CRASH Co-ordinating Centre
Institute of Child Health
30 Guilford Street
London
WC1N 1EH
United Kingdom

Study information

Study designPlacebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Participant information sheet Patient information can be found at: http://www.crash.lshtm.ac.uk/TP_English_PatRelSheet.htm
Scientific title
Study acronymCRASH
Study objectivesThe aim of the pilot phase was to determine whether a large-scale trial is feasible in the emergency setting, and to test and refine the study procedures for the main phase of the CRASH trial. The pilot phase was to be conducted over a one-year period.

The CRASH trial aims to determine reliably:
1. The effects of high dose corticosteroid infusion on death and on disability following significant head injury
2. The effects of such infusion on the risk of infection and of gastro-intestinal bleeding in this setting

Protocol can be found at: http://www.crash.lshtm.ac.uk/Trial_Protocol_English.html
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNeuroscience, psychiatry
Intervention1. Intervention: 48 hour infusion of methylprednisolone (MP) (0.4 g/h for 48 hours)
2. Control: placebo infusion
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Methylprednisolone
Primary outcome measure1. Death from any cause within two weeks of injury
2. Death or dependence at six months
Secondary outcome measuresNot provided at time of registration
Overall study start date01/04/1999
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants10000
Key inclusion criteriaHead injured patients (judged to be 16 years or older) within 8 hours of injury who are not fully conscious (any abnormality on the Glasgow Coma Scale), except those for whom corticosteroids are thought to be clearly indicated or contra-indicated. There are no other pre-specified exclusion criteria, as the fundamental eligibility criterion is the responsible doctor's uncertainty whether or not to use corticosteroids in a particular adult with head injury.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/04/1999
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

CRASH Co-ordinating Centre
London
WC1N 1EH
United Kingdom

Sponsor information

London School of Hygiene and Tropical Medicine (UK)
University/education

Keppel Street
London
WC1E 7HT
England
United Kingdom

Phone +44 (0)20 7636 8636
Website http://www.lshtm.ac.uk
ROR logo "ROR" https://ror.org/00a0jsq62

Funders

Funder type

Research council

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 11/06/2001 Yes No
Results article results 01/10/2004 Yes No
Results article results 01/06/2005 Yes No